Results 11 to 20 of about 33,124 (331)

Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device

Circulation, 2021
Supplemental Digital Content is available in the text. Background: Left atrial appendage (LAA) occlusion provides an alternative to oral anticoagulation for thromboembolic risk reduction in patients with nonvalvular atrial fibrillation.
S. Kar, S. Doshi, A. Sadhu, R. Horton, J. Osorio, C. Ellis, James Stone, Manish H. Shah, S. Dukkipati, S. Adler, Devi G. Nair, Jamie H. Kim, O. Wazni, Mathew J. Price, F. Asch, D. Holmes, Robert D. Shipley, N. Gordon, D. Allocco, V. Reddy   +19 more
semanticscholar   +3 more sources

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.

Journal of the American College of Cardiology, 2020
BACKGROUND Percutaneous left atrial appendage closure (LAAC) is noninferior to vitamin K antagonists (VKAs) for preventing atrial fibrillation (AF)-related stroke. However, direct oral anticoagulants (DOACs) have an improved safety profile over VKAs, and
P. Osmančík, D. Heřman, P. Neužil, P. Hála, M. Táborský, P. Kala, M. Poloczek, J. Šťásek, L. Haman, M. Branny, J. Chovancik, P. Červinka, J. Holý, T. Kovárník, D. Zemánek, Š. Havránek, V. Vancura, J. Opatrny, P. Peichl, P. Toušek, V. Lekešová, J. Jarkovský, Martina Nováčková, K. Benešová, P. Widimsky, V. Reddy   +25 more
semanticscholar   +3 more sources

Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions

US Cardiology Review, 2023
Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF.
Chirag Bavishi
doaj   +1 more source

Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis

Anatolian Journal of Cardiology, 2022
Background: Catheter ablation combined with left atrial appendage closure is effective in treating atrial fibrillation. However, the effectiveness of this combined treatment compared with catheter ablation alone is still controversial.
An Wang, Jingbo Jiang, Zhitao Xie, Guoqiang Zhong   +3 more
doaj   +1 more source

Different Techniques of Surgical Left Atrial Appendage Closure and Their Efficacy: A Systematic Review

Reviews in Cardiovascular Medicine, 2023
Background: Atrial fibrillation has been identified as an independent risk factor for thromboembolic events. Since 1948 different surgical techniques have described the feasibility and the rationale of left atrial surgical appendage closure.
Mizar D'Abramo, Silvia Romiti, Sara Saltarocchi, Wael Saade, Flaminia Spunticchia, Noemi Bruno, Mariangela Peruzzi, Fabio Miraldi, Giacomo Frati, Ernesto Greco, Francesco Macrina, Paolo De Orchi, Antonino G. M. Marullo   +12 more
doaj   +1 more source

Case report: pulmonary artery perforation during transseptal puncture for left atrial appendage closure requires emergency cardiac operation

Frontiers in Cardiovascular Medicine, 2023
Patients with atrial fibrillation who take a high bleeding risk and are not candidates for oral anticoagulation therapy are increasingly being referred for left atrial appendage closure (LAAC) as an alternative method of stroke prevention.
Yue Wang, Yue Wang, Beibei Song, Bing Liu, Hui Zhang, Chenglong Bi, Wenhao Liu, Wenhao Liu, Gang Ma, Bo Li   +9 more
doaj   +1 more source

Device-Based Left Atrial Appendage Closure [PDF]

Circulation: Arrhythmia and Electrophysiology, 2011
A 56-year-old man with symptomatic paroxysmal atrial fibrillation refractory to both conventional antiarrhythmic drug therapy and catheter ablation was referred for transcatheter left atrial appendage (LAA) closure. The presence of hypertrophic cardiomyopathy with enlarged left atrial diameter (50 mm), heart failure, recurrent episodes of refractory ...
Pappone C, Vicedomini G, Cremonesi A, Zuffada F, Santinelli V   +4 more
openaire   +3 more sources

Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.

Journal of the American College of Cardiology, 2021
BACKGROUND The PRAGUE-17 trial demonstrated that left atrial appendage closure (LAAC) was non-inferior to non-warfarin oral anticoagulants (NOAC) for preventing major neurological, cardiovascular or bleeding events in high-risk patients with atrial ...
P. Osmančík, D. Heřman, P. Neužil, P. Hála, M. Táborský, P. Kala, M. Poloczek, J. Šťásek, L. Haman, M. Branny, J. Chovancik, P. Červinka, Jiří Holý, T. Kovárník, D. Zemánek, Š. Havránek, V. Vancura, P. Peichl, P. Toušek, V. Lekešová, J. Jarkovský, Martina Nováčková, K. Benešová, P. Widimsky, V. Reddy   +24 more
semanticscholar   +1 more source

Late Presentation of Pulmonary Artery-Left Atrial Appendage Fistula Formation After Left Atrial Appendage Device Closure

JACC: Case Reports, 2020
Atrial fibrillation is the most common arrhythmia in clinical practice with indication for anticoagulation in those patients whose annual risk for thromboembolism is >2%. Left atrial appendage closure is growing as an alternative to anticoagulation.
Wayne H. Miller, MD, Sandhya Dhruvakumar, MD, Mina C. Owlia, MD, Greg R. D’Onofrio, MD, David Hsi, MD   +4 more
doaj   +1 more source

Short and Intermediate Term Outcomes of the Convergent Procedure: Initial Experience in a Tertiary Referral Center [PDF]

, 2020
PURPOSE: The Convergent procedure is a hybrid, multidisciplinary treatment for symptomatic atrial fibrillation (AF) consisting of minimally invasive surgical epicardial ablation and percutaneous/catheter endocardial ablation.
Hirsh, Jeffrey, Lantz, Gurion, Lee, Lawrence S., Mahlow, Jeremy, Tonks, Robert   +4 more
core   +1 more source